Pharma & Healthcare
Global Alzheimer's Disease Drug Market Research Report 2024
- Jan 26, 24
- ID: 39388
- Pages: 80
- Figures: 185
- Views: 20
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer's Disease Drug market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4020.5 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug.
Report Scope
The Alzheimer's Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Type
Donepezil
Memantine
Rivastigmine
Others
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alzheimer's Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Alzheimer's Disease Drug market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4020.5 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug.
Report Scope
The Alzheimer's Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Type
Donepezil
Memantine
Rivastigmine
Others
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alzheimer's Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Alzheimer's Disease Drug Market Overview
1.1 Product Overview and Scope of Alzheimer's Disease Drug
1.2 Alzheimer's Disease Drug Segment by Type
1.2.1 Global Alzheimer's Disease Drug Market Value Comparison by Type (2024-2030)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Alzheimer's Disease Drug Segment by Application
1.3.1 Global Alzheimer's Disease Drug Market Value by Application: (2024-2030)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Alzheimer's Disease Drug Revenue 2019-2030
1.4.2 Global Alzheimer's Disease Drug Sales 2019-2030
1.4.3 Global Alzheimer's Disease Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alzheimer's Disease Drug Market Competition by Manufacturers
2.1 Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alzheimer's Disease Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alzheimer's Disease Drug Average Price by Manufacturers (2019-2024)
2.4 Global Alzheimer's Disease Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alzheimer's Disease Drug, Product Type & Application
2.7 Alzheimer's Disease Drug Market Competitive Situation and Trends
2.7.1 Alzheimer's Disease Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alzheimer's Disease Drug Players Market Share by Revenue
2.7.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alzheimer's Disease Drug Retrospective Market Scenario by Region
3.1 Global Alzheimer's Disease Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alzheimer's Disease Drug Global Alzheimer's Disease Drug Sales by Region: 2019-2030
3.2.1 Global Alzheimer's Disease Drug Sales by Region: 2019-2024
3.2.2 Global Alzheimer's Disease Drug Sales by Region: 2025-2030
3.3 Global Alzheimer's Disease Drug Global Alzheimer's Disease Drug Revenue by Region: 2019-2030
3.3.1 Global Alzheimer's Disease Drug Revenue by Region: 2019-2024
3.3.2 Global Alzheimer's Disease Drug Revenue by Region: 2025-2030
3.4 North America Alzheimer's Disease Drug Market Facts & Figures by Country
3.4.1 North America Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alzheimer's Disease Drug Sales by Country (2019-2030)
3.4.3 North America Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alzheimer's Disease Drug Market Facts & Figures by Country
3.5.1 Europe Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alzheimer's Disease Drug Sales by Country (2019-2030)
3.5.3 Europe Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alzheimer's Disease Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alzheimer's Disease Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country
3.7.1 Latin America Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alzheimer's Disease Drug Sales by Country (2019-2030)
3.7.3 Latin America Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alzheimer's Disease Drug Sales by Type (2019-2030)
4.1.1 Global Alzheimer's Disease Drug Sales by Type (2019-2024)
4.1.2 Global Alzheimer's Disease Drug Sales by Type (2025-2030)
4.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)
4.2 Global Alzheimer's Disease Drug Revenue by Type (2019-2030)
4.2.1 Global Alzheimer's Disease Drug Revenue by Type (2019-2024)
4.2.2 Global Alzheimer's Disease Drug Revenue by Type (2025-2030)
4.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)
4.3 Global Alzheimer's Disease Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Alzheimer's Disease Drug Sales by Application (2019-2030)
5.1.1 Global Alzheimer's Disease Drug Sales by Application (2019-2024)
5.1.2 Global Alzheimer's Disease Drug Sales by Application (2025-2030)
5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)
5.2 Global Alzheimer's Disease Drug Revenue by Application (2019-2030)
5.2.1 Global Alzheimer's Disease Drug Revenue by Application (2019-2024)
5.2.2 Global Alzheimer's Disease Drug Revenue by Application (2025-2030)
5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)
5.3 Global Alzheimer's Disease Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Alzheimer's Disease Drug Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Alzheimer's Disease Drug Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Alzheimer's Disease Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 Merz Pharma
6.5.1 Merz Pharma Corporation Information
6.5.2 Merz Pharma Description and Business Overview
6.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merz Pharma Alzheimer's Disease Drug Product Portfolio
6.5.5 Merz Pharma Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Alzheimer's Disease Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Alzheimer's Disease Drug Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Lundbeck
6.8.1 Lundbeck Corporation Information
6.8.2 Lundbeck Description and Business Overview
6.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lundbeck Alzheimer's Disease Drug Product Portfolio
6.8.5 Lundbeck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alzheimer's Disease Drug Industry Chain Analysis
7.2 Alzheimer's Disease Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alzheimer's Disease Drug Production Mode & Process
7.4 Alzheimer's Disease Drug Sales and Marketing
7.4.1 Alzheimer's Disease Drug Sales Channels
7.4.2 Alzheimer's Disease Drug Distributors
7.5 Alzheimer's Disease Drug Customers
8 Alzheimer's Disease Drug Market Dynamics
8.1 Alzheimer's Disease Drug Industry Trends
8.2 Alzheimer's Disease Drug Market Drivers
8.3 Alzheimer's Disease Drug Market Challenges
8.4 Alzheimer's Disease Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Alzheimer's Disease Drug
1.2 Alzheimer's Disease Drug Segment by Type
1.2.1 Global Alzheimer's Disease Drug Market Value Comparison by Type (2024-2030)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Alzheimer's Disease Drug Segment by Application
1.3.1 Global Alzheimer's Disease Drug Market Value by Application: (2024-2030)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Alzheimer's Disease Drug Revenue 2019-2030
1.4.2 Global Alzheimer's Disease Drug Sales 2019-2030
1.4.3 Global Alzheimer's Disease Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alzheimer's Disease Drug Market Competition by Manufacturers
2.1 Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alzheimer's Disease Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alzheimer's Disease Drug Average Price by Manufacturers (2019-2024)
2.4 Global Alzheimer's Disease Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alzheimer's Disease Drug, Product Type & Application
2.7 Alzheimer's Disease Drug Market Competitive Situation and Trends
2.7.1 Alzheimer's Disease Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alzheimer's Disease Drug Players Market Share by Revenue
2.7.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alzheimer's Disease Drug Retrospective Market Scenario by Region
3.1 Global Alzheimer's Disease Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alzheimer's Disease Drug Global Alzheimer's Disease Drug Sales by Region: 2019-2030
3.2.1 Global Alzheimer's Disease Drug Sales by Region: 2019-2024
3.2.2 Global Alzheimer's Disease Drug Sales by Region: 2025-2030
3.3 Global Alzheimer's Disease Drug Global Alzheimer's Disease Drug Revenue by Region: 2019-2030
3.3.1 Global Alzheimer's Disease Drug Revenue by Region: 2019-2024
3.3.2 Global Alzheimer's Disease Drug Revenue by Region: 2025-2030
3.4 North America Alzheimer's Disease Drug Market Facts & Figures by Country
3.4.1 North America Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alzheimer's Disease Drug Sales by Country (2019-2030)
3.4.3 North America Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alzheimer's Disease Drug Market Facts & Figures by Country
3.5.1 Europe Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alzheimer's Disease Drug Sales by Country (2019-2030)
3.5.3 Europe Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alzheimer's Disease Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alzheimer's Disease Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country
3.7.1 Latin America Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alzheimer's Disease Drug Sales by Country (2019-2030)
3.7.3 Latin America Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alzheimer's Disease Drug Sales by Type (2019-2030)
4.1.1 Global Alzheimer's Disease Drug Sales by Type (2019-2024)
4.1.2 Global Alzheimer's Disease Drug Sales by Type (2025-2030)
4.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)
4.2 Global Alzheimer's Disease Drug Revenue by Type (2019-2030)
4.2.1 Global Alzheimer's Disease Drug Revenue by Type (2019-2024)
4.2.2 Global Alzheimer's Disease Drug Revenue by Type (2025-2030)
4.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)
4.3 Global Alzheimer's Disease Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Alzheimer's Disease Drug Sales by Application (2019-2030)
5.1.1 Global Alzheimer's Disease Drug Sales by Application (2019-2024)
5.1.2 Global Alzheimer's Disease Drug Sales by Application (2025-2030)
5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)
5.2 Global Alzheimer's Disease Drug Revenue by Application (2019-2030)
5.2.1 Global Alzheimer's Disease Drug Revenue by Application (2019-2024)
5.2.2 Global Alzheimer's Disease Drug Revenue by Application (2025-2030)
5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)
5.3 Global Alzheimer's Disease Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Alzheimer's Disease Drug Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Alzheimer's Disease Drug Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Alzheimer's Disease Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 Merz Pharma
6.5.1 Merz Pharma Corporation Information
6.5.2 Merz Pharma Description and Business Overview
6.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merz Pharma Alzheimer's Disease Drug Product Portfolio
6.5.5 Merz Pharma Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Alzheimer's Disease Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Alzheimer's Disease Drug Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Lundbeck
6.8.1 Lundbeck Corporation Information
6.8.2 Lundbeck Description and Business Overview
6.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lundbeck Alzheimer's Disease Drug Product Portfolio
6.8.5 Lundbeck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alzheimer's Disease Drug Industry Chain Analysis
7.2 Alzheimer's Disease Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alzheimer's Disease Drug Production Mode & Process
7.4 Alzheimer's Disease Drug Sales and Marketing
7.4.1 Alzheimer's Disease Drug Sales Channels
7.4.2 Alzheimer's Disease Drug Distributors
7.5 Alzheimer's Disease Drug Customers
8 Alzheimer's Disease Drug Market Dynamics
8.1 Alzheimer's Disease Drug Industry Trends
8.2 Alzheimer's Disease Drug Market Drivers
8.3 Alzheimer's Disease Drug Market Challenges
8.4 Alzheimer's Disease Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Alzheimer's Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Alzheimer's Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Alzheimer's Disease Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Alzheimer's Disease Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Alzheimer's Disease Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Alzheimer's Disease Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Alzheimer's Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alzheimer's Disease Drug, Product Type & Application
Table 12. Global Key Manufacturers of Alzheimer's Disease Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Alzheimer's Disease Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Alzheimer's Disease Drug Sales Market Share by Region (2019-2024)
Table 19. Global Alzheimer's Disease Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Alzheimer's Disease Drug Sales Market Share by Region (2025-2030)
Table 21. Global Alzheimer's Disease Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Alzheimer's Disease Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Alzheimer's Disease Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Alzheimer's Disease Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Alzheimer's Disease Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Alzheimer's Disease Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Alzheimer's Disease Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Alzheimer's Disease Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Alzheimer's Disease Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Alzheimer's Disease Drug Sales Market Share by Type (2019-2024)
Table 53. Global Alzheimer's Disease Drug Sales Market Share by Type (2025-2030)
Table 54. Global Alzheimer's Disease Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Alzheimer's Disease Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Alzheimer's Disease Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Alzheimer's Disease Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Alzheimer's Disease Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Alzheimer's Disease Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Alzheimer's Disease Drug Sales Market Share by Application (2019-2024)
Table 63. Global Alzheimer's Disease Drug Sales Market Share by Application (2025-2030)
Table 64. Global Alzheimer's Disease Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Alzheimer's Disease Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Alzheimer's Disease Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Alzheimer's Disease Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Allergan Alzheimer's Disease Drug Product
Table 74. Allergan Recent Developments/Updates
Table 75. Eisai Corporation Information
Table 76. Eisai Description and Business Overview
Table 77. Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eisai Alzheimer's Disease Drug Product
Table 79. Eisai Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Alzheimer's Disease Drug Product
Table 84. Novartis Recent Developments/Updates
Table 85. Daiichi Sankyo Corporation Information
Table 86. Daiichi Sankyo Description and Business Overview
Table 87. Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Daiichi Sankyo Alzheimer's Disease Drug Product
Table 89. Daiichi Sankyo Recent Developments/Updates
Table 90. Merz Pharma Corporation Information
Table 91. Merz Pharma Description and Business Overview
Table 92. Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merz Pharma Alzheimer's Disease Drug Product
Table 94. Merz Pharma Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Alzheimer's Disease Drug Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Johnson & Johnson Alzheimer's Disease Drug Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Lundbeck Corporation Information
Table 106. Lundbeck Description and Business Overview
Table 107. Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Lundbeck Alzheimer's Disease Drug Product
Table 109. Lundbeck Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Alzheimer's Disease Drug Distributors List
Table 113. Alzheimer's Disease Drug Customers List
Table 114. Alzheimer's Disease Drug Market Trends
Table 115. Alzheimer's Disease Drug Market Drivers
Table 116. Alzheimer's Disease Drug Market Challenges
Table 117. Alzheimer's Disease Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alzheimer's Disease Drug
Figure 2. Global Alzheimer's Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Alzheimer's Disease Drug Market Share by Type in 2023 & 2030
Figure 4. Donepezil Product Picture
Figure 5. Memantine Product Picture
Figure 6. Rivastigmine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Alzheimer's Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Alzheimer's Disease Drug Market Share by Application in 2023 & 2030
Figure 10. Early to Moderate Stages
Figure 11. Moderate to Severe Stages
Figure 12. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Alzheimer's Disease Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global Alzheimer's Disease Drug Sales (2019-2030) & (K Units)
Figure 15. Global Alzheimer's Disease Drug Average Price (USD/Unit) & (2019-2030)
Figure 16. Alzheimer's Disease Drug Report Years Considered
Figure 17. Alzheimer's Disease Drug Sales Share by Manufacturers in 2023
Figure 18. Global Alzheimer's Disease Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Alzheimer's Disease Drug Players: Market Share by Revenue in 2023
Figure 20. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Alzheimer's Disease Drug Sales Market Share by Country (2019-2030)
Figure 23. North America Alzheimer's Disease Drug Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Alzheimer's Disease Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Region (2019-2030)
Figure 35. China Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Alzheimer's Disease Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Alzheimer's Disease Drug Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Alzheimer's Disease Drug Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Alzheimer's Disease Drug by Type (2019-2030)
Figure 56. Global Revenue Market Share of Alzheimer's Disease Drug by Type (2019-2030)
Figure 57. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Alzheimer's Disease Drug by Application (2019-2030)
Figure 59. Global Revenue Market Share of Alzheimer's Disease Drug by Application (2019-2030)
Figure 60. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2019-2030)
Figure 61. Alzheimer's Disease Drug Value Chain
Figure 62. Alzheimer's Disease Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Alzheimer's Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Alzheimer's Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Alzheimer's Disease Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Alzheimer's Disease Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Alzheimer's Disease Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Alzheimer's Disease Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Alzheimer's Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alzheimer's Disease Drug, Product Type & Application
Table 12. Global Key Manufacturers of Alzheimer's Disease Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Alzheimer's Disease Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Alzheimer's Disease Drug Sales Market Share by Region (2019-2024)
Table 19. Global Alzheimer's Disease Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Alzheimer's Disease Drug Sales Market Share by Region (2025-2030)
Table 21. Global Alzheimer's Disease Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Alzheimer's Disease Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Alzheimer's Disease Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Alzheimer's Disease Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Alzheimer's Disease Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Alzheimer's Disease Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Alzheimer's Disease Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Alzheimer's Disease Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Alzheimer's Disease Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Alzheimer's Disease Drug Sales Market Share by Type (2019-2024)
Table 53. Global Alzheimer's Disease Drug Sales Market Share by Type (2025-2030)
Table 54. Global Alzheimer's Disease Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Alzheimer's Disease Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Alzheimer's Disease Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Alzheimer's Disease Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Alzheimer's Disease Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Alzheimer's Disease Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Alzheimer's Disease Drug Sales Market Share by Application (2019-2024)
Table 63. Global Alzheimer's Disease Drug Sales Market Share by Application (2025-2030)
Table 64. Global Alzheimer's Disease Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Alzheimer's Disease Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Alzheimer's Disease Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Alzheimer's Disease Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Allergan Alzheimer's Disease Drug Product
Table 74. Allergan Recent Developments/Updates
Table 75. Eisai Corporation Information
Table 76. Eisai Description and Business Overview
Table 77. Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eisai Alzheimer's Disease Drug Product
Table 79. Eisai Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Alzheimer's Disease Drug Product
Table 84. Novartis Recent Developments/Updates
Table 85. Daiichi Sankyo Corporation Information
Table 86. Daiichi Sankyo Description and Business Overview
Table 87. Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Daiichi Sankyo Alzheimer's Disease Drug Product
Table 89. Daiichi Sankyo Recent Developments/Updates
Table 90. Merz Pharma Corporation Information
Table 91. Merz Pharma Description and Business Overview
Table 92. Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merz Pharma Alzheimer's Disease Drug Product
Table 94. Merz Pharma Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Alzheimer's Disease Drug Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Johnson & Johnson Alzheimer's Disease Drug Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Lundbeck Corporation Information
Table 106. Lundbeck Description and Business Overview
Table 107. Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Lundbeck Alzheimer's Disease Drug Product
Table 109. Lundbeck Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Alzheimer's Disease Drug Distributors List
Table 113. Alzheimer's Disease Drug Customers List
Table 114. Alzheimer's Disease Drug Market Trends
Table 115. Alzheimer's Disease Drug Market Drivers
Table 116. Alzheimer's Disease Drug Market Challenges
Table 117. Alzheimer's Disease Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alzheimer's Disease Drug
Figure 2. Global Alzheimer's Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Alzheimer's Disease Drug Market Share by Type in 2023 & 2030
Figure 4. Donepezil Product Picture
Figure 5. Memantine Product Picture
Figure 6. Rivastigmine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Alzheimer's Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Alzheimer's Disease Drug Market Share by Application in 2023 & 2030
Figure 10. Early to Moderate Stages
Figure 11. Moderate to Severe Stages
Figure 12. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Alzheimer's Disease Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global Alzheimer's Disease Drug Sales (2019-2030) & (K Units)
Figure 15. Global Alzheimer's Disease Drug Average Price (USD/Unit) & (2019-2030)
Figure 16. Alzheimer's Disease Drug Report Years Considered
Figure 17. Alzheimer's Disease Drug Sales Share by Manufacturers in 2023
Figure 18. Global Alzheimer's Disease Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Alzheimer's Disease Drug Players: Market Share by Revenue in 2023
Figure 20. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Alzheimer's Disease Drug Sales Market Share by Country (2019-2030)
Figure 23. North America Alzheimer's Disease Drug Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Alzheimer's Disease Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Region (2019-2030)
Figure 35. China Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Alzheimer's Disease Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Alzheimer's Disease Drug Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Alzheimer's Disease Drug Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Alzheimer's Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Alzheimer's Disease Drug by Type (2019-2030)
Figure 56. Global Revenue Market Share of Alzheimer's Disease Drug by Type (2019-2030)
Figure 57. Global Alzheimer's Disease Drug Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Alzheimer's Disease Drug by Application (2019-2030)
Figure 59. Global Revenue Market Share of Alzheimer's Disease Drug by Application (2019-2030)
Figure 60. Global Alzheimer's Disease Drug Price (USD/Unit) by Application (2019-2030)
Figure 61. Alzheimer's Disease Drug Value Chain
Figure 62. Alzheimer's Disease Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232